OBJECTIVE: The purpose of this study was to determine the frequency of @entity260 after bronchoplastic procedures in the treatment of @entity5 and to analyze the factors influencing the complication rate. METHODS: During a 5-year-period (1992-1996) 79 @entity1 (68 male, 11 female, mean age 57 years) underwent reconstructive operations for @entity5 . We performed 58 bronchoplastic procedures and 21 combined broncho- and angioplastic procedures. Among the bronchoplastic procedures the number of sleeve resections (n = 44) and wedge resections (n = 35) were comparable. RESULTS: Fifty-nine @entity1 (74,7%) showed a regular postoperative course; 12 @entity1 (15,2%) had severe @entity260 ( @entity204 , re-operation). Concerning the primary operation the operative 30-day mortality was 5.1% (n = 4) and including the two deaths after re-operation it was 7.6% (n = 6). After subdividing the @entity1 into three groups (severe, less severe and no complications) we tried to determine predictors for occurrence of @entity260 . There was a higher rate of severe complications in the age group 61-70 years (6/25 = 24%) as compared with younger @entity1 between 51 and 60 years (4/38 = 10,5%; P < 0,05). Concerning the location, the outcome was better after sleeve- or wedge lobectomies of the upper lobes (four complications/51 @entity1 = 7.8%) compared with procedures of the lower lobes (3/14 = 21.4%). The data could not prove a lower frequency of severe @entity260 or specific morbidity after @entity456 following bronchial sleeve resection. The complication rate was higher when sleeve resection of the bronchus was performed (10/44 = 22.7%) as compared with wedge resections (2/35 = 5.7%; P = 0,011) and after resection of T3/T4 @entity5 (6/28 = 21,4%) compared with @entity6493 @entity5 (4/37 = 10.8%; P < 0,05). CONCLUSIONS: Bronchoplastic procedures represent a fairly safe therapy opportunity in @entity1 with centrally localized @entity153 and compromised or uncompromised pulmonary function. In this study the complication rate was higher after sleeve resection of the bronchus as compared with wedge resection. Pleural coverage of the @entity254 was not effective to prevent @entity532 due to dehiscence of the bronchial @entity254 . A pedicled @entity121 could be a valuable alternative.

XXXX after bronchoplastic procedures in the treatment of @entity5 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity6493 :: ('9173;292', 'Gene') :: ['T1/T2'] @entity5 :: ('MESH:D009369', 'Disease') :: ['bronchial malignancies', 'tumors', 'pulmonary malignant tumors'] @entity254 :: ('MESH:C563598', 'Disease') :: ['anastomosis'] @entity532 :: ('MESH:D003925', 'Disease') :: ['major complications'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity153 :: ('MESH:D002283', 'Disease') :: ['bronchial carcinoma'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity121 :: ('MESH:D009135', 'Disease') :: ['muscle flap'] @entity456 :: ('MESH:D010995', 'Disease') :: ['pleural coverage']
@entity260 :: (MESH:D011183,Disease) :: ['Postoperative complications']
